logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Dongyangguang Pharma (06887.HK) repurchased 16,000 shares for HKD 635,500 on September 28.

date
28/09/2026
Zhitong Finance APP News, Sunshine Lake Pharma (06887.HK) announced that on September 28, 2026, the company spent HK$635,500 to repurchase 16,000 shares at a repurchase price of HK$39.4 to HK$40 per share.
Latest
3 m ago
Sanxia New Material: Plans to acquire no less than 53.14% of Saiwei's shares and suspend trading.
3 m ago
RedCare Pharmacy NV expects revenue from its German prescription business to reach EUR 730 million to EUR 760 million in 2026, representing year-on-year growth of 45% to 51%.
3 m ago
Three Gorges New Materials: SDIC's transfer of 85% equity in Dangyang Urban Investment has not yet completed industrial and commercial change registration.
4 m ago
AI giants join forces with labor unions to push for data center development
4 m ago
Infore Environment: Cumulative repurchase of 7.5139 million shares, payment of RMB 58.7057 million
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.